Back Stocks profile

Stock analysis tool for investors

Brooks Laboratories Ltd.

NSE: BROOKS | BSE:533543

₹85.73 0.10 (0.12%) 1D

Pharmaceuticals & Biotechnology

Open an Account with Bigul in 5 minutes

Performance

Today’s low

85.00

Today’s High

88.80

52W low

73.20

52W High

185.70

Open Price

88.50

Prev. Close

76.1000

Volume

38928.00

Value

3337297.44

Fundamentals

Market Cap Cr

225.00

Price to Earnings

-11.50

Price to Book Value

3.40

Dividend Yield

0.00

PE to Growth

-0.40

Op Revenue TTM Cr

79.49

Net Profit TTM Cr

-19.59

Cash From Operating Activity Cr

-9.68

Return on Equity %

-29.87

EMA & SMA

Bullish Moving Averages

2

Bearish Moving Averages

14

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 Jul, 2024

100

Week

100

Month

100

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

85.86

PIVOT

First Resistance

87.22

Second Resistance

88.82

Third Resistance

90.18

First Support

84.26

Second Support

82.90

Third Support

81.30

Relative Strength Index

47.36

Money Flow Index

61.8

MACD

-0.56

MACD Signal

-1.2

Average True Range

3.95

Average Directional Index

14

Rate of Change (21)

6.37

Rate of Change (125)

-40.37

Commodity Channel Index

32.7

Williams %R

-53.5

BETA

1 Month

0.38

3 Month

0.51

1 Year

0.81

3 Year

0.5

PRICE CHANGE ANALYSIS

-0.86%

1 Week

Low

High

84

90.85

6.5%

1 Month

Low

High

73.25

92

-16.44%

3 Months

Low

High

73.25

116

-39.69%

6 Months

Low

High

73.25

185.7

10.19%

1 Year

Low

High

73.25

185.7

Bigul
26 Jun 2024

BROOKS LABORATORIES LTD. - 533543 - Closure of Trading Window

Intimation for Closure of Trading Window.
Bigul
27 May 2024

BROOKS LABORATORIES LTD. - 533543 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2024
Bigul
18 May 2024

BROOKS LABORATORIES LTD. - 533543 - Financial Results For Quarter And Financial Year Ended March 31, 2024

Financial Results for Quarter and Financial Year ended March 31,2024
Bigul
18 May 2024

BROOKS LABORATORIES LTD. - 533543 - Board Meeting Outcome for Board Meeting Outcome For Submission Of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2024.

Board Meeting Outcome For Submission of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2024.
Bigul
12 May 2024

BROOKS LABORATORIES LTD. - 533543 - Board Meeting Intimation for Approval Of Audited Financial Results For March 31, 2024

BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended 31st March 2024.
Bigul
10 Apr 2024

BROOKS LABORATORIES LTD. - 533543 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for quarter ended March 31,2024
Bigul
06 Apr 2024

BROOKS LABORATORIES LTD. - 533543 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Revised Proceedings and Outcome of 21st AGM held on 21st September, 2023.
See all News

FAQs

The latest market price of Brooks Laboratories Ltd. on NSE was Rs. 85.73 as of today.

The opening share price of Brooks Laboratories Ltd. was Rs. 88.50 as of today.

The 52-week high share price of Brooks Laboratories Ltd. was Rs. 185.70.

The 52 week low share price of Brooks Laboratories Ltd. was Rs. 73.20.

Brooks Laboratories Ltd. has a market cap of Rs. 225.00 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Brooks Laboratories Ltd. is -0.40. Please refer to the Fundamentals section for further details.

The operating revenue for Brooks Laboratories Ltd. in the last FY was Rs.  79.49 crore. Please refer to the Financials section for further details.

The Net Profit for Brooks Laboratories Ltd. in the last FY was Rs. -19.59 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Brooks Laboratories Ltd..

Close

Let's Open Free Demat Account